Literature DB >> 25069792

Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation.

Min Zhang1, Jie Wang, Jingjing Jiang, Xiaohui Zhan, Yan Ling, Zhiqiang Lu, Jianming Guo, Xin Gao.   

Abstract

Von Hippel-Lindau (VHL) disease is an autosomal dominant syndrome caused by germline mutations in the synonymous VHL gene encoding a tumor suppressor. Affected individuals are susceptible to various benign and malignant tumors. Based on the phenotypes, VHL disease is classified as type 1 and type 2. Here, we describe a Chinese family diagnosed as VHL disease type 2, with different metabolic status of tumors on FDG PET-CT. Genetic analysis revealed a germline c.264G>A point mutation, resulting in premature termination at codon 88 (p.W88X). This pedigree represents a rare link between p.W88X nonsense mutation (genotype) and VHL disease type 2 (phenotype), which has not been previously described. This is also the first nonsense mutation to manifest as VHL disease type 2 in ethnic Chinese. We also reviewed the literature and provided an outline of mutations associated with VHL disease in China.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25069792     DOI: 10.1007/s12020-014-0368-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  30 in total

1.  High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil.

Authors:  J C C Rocha; R L A Silva; B B Mendonça; S Marui; A J G Simpson; A A Camargo
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

2.  Genetic characterization and protein stability analysis of a Chinese family with Von Hippel-Lindau disease.

Authors:  Yong Gao; Yan-ping Huang; Xiang-an Tu; Dao-sheng Luo; Dao-hu Wang; Shao-peng Qiu; Peng Xiang; Wei-qiang Li; Rohozinski Jan; Yuan-yuan Zhang; Xiang-zhou Sun; Chun-hua Deng
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

3.  [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].

Authors:  Yu Su; Wei-dong Shen; Cui-cui Wang; Wei-ju Han; Jun Liu; Zhao-hui Hou; Zhi-gang Song; De-liang Huang; Dong-yi Han; Shi-ming Yang
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2013-11

4.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

5.  Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.

Authors:  S Olschwang; S Richard; C Boisson; S Giraud; P Laurent-Puig; F Resche; G Thomas
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

6.  A c.464T>a mutation in VHL gene in a Chinese family with VHL syndrome.

Authors:  Yan Lu; Jun Lu; Qiang Liu; Jian Niu; Shi-Ming Zhang; Qing-Yu Wu; Xiao-Fei Qi
Journal:  J Neurooncol       Date:  2012-12-01       Impact factor: 4.130

7.  Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Authors:  F Chen; T Kishida; M Yao; T Hustad; D Glavac; M Dean; J R Gnarra; M L Orcutt; F M Duh; G Glenn
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.

Authors:  Dandan Jia; Beisha Tang; Yuting Shi; Junling Wang; Zhanfang Sun; Zhao Chen; Li Zhang; Kun Xia; Hong Jiang
Journal:  J Clin Neurosci       Date:  2013-04-28       Impact factor: 1.961

10.  Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: A case report and review of literature.

Authors:  Shrikant Solav; Ritu Bhandari
Journal:  Indian J Nucl Med       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.